Comparison of the therapeutic efficacy of fluoroquinolone and non-fluoroquinolone treatment in patients with Elizabethkingia meningoseptica bacteraemia-Reference-Cited by-同舟云学术

Comparison of the therapeutic efficacy of fluoroquinolone and non-fluoroquinolone treatment in patients with Elizabethkingia meningoseptica bacteraemia

Published:2018-01 Issue:1 Volume:51 Page:47-51
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Huang Ying-Chi,Lin Yi-Tsung,Wang Fu-Der

Funder

Ministry of Science and Technology of Taiwan

Szu-Yuan Research Foundation of Internal Medicine

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference27 articles.

1. Transfer of Chryseobacterium meningosepticum and Chryseobacterium miricola to Elizabethkingia gen. nov. as Elizabethkingia meningoseptica comb. nov. and Elizabethkingia miricola comb. nov;Kim;Int J Syst Evol Microbiol,2005

2. Atypical Chryseobacterium meningosepticum and meningitis and sepsis in newborns and the immunocompromised, Taiwan;Chiu;Emerg Infect Dis,2000

3. Cryseobacterium meningosepticum: an emerging pathogen among immunocompromised adults. Report of 6 cases and literature review;Bloch;Medicine (Baltimore),1997

4. Waterborne Elizabethkingia meningoseptica in adult critical care;Moore;Emerg Infect Dis,2016

5. Bad design, bad practices, bad bugs: frustrations in controlling an outbreak of Elizabethkingia meningoseptica in intensive care units;Balm;J Hosp Infect,2013

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Characteristics and Risk Factors for Infection and Death in Critically Ill Patients with Pulmonary Infection with Elizabethkingia Spp.;Infection and Drug Resistance;2024-06

2. Clinical manifestations, antimicrobial resistance and genomic feature analysis of multidrug-resistant Elizabethkingia strains;Annals of Clinical Microbiology and Antimicrobials;2024-04-10

3. Preferred Therapy for Specific Bacterial and Mycobacterial Pathogens;2024 Nelson’s Pediatric Antimicrobial Therapy;2024-02-12

4. Probability of outbreaks and cross-border dissemination of the emerging pathogen: a genomic survey of Elizabethkingia meningoseptica;Microbiology Spectrum;2023-12-12

5. Elizabethkingia meningoseptica: Changing anti microbial resistance causing fatal community-acquired neonatal meningitis – An area of rising concern;Wadia Journal of Women and Child Health;2023-10-10